October 2009 Updates
September 2009 Updates
August 2009 Updates
July 2009 Updates
June 2009 Updates
May 2009 Updates
April 2009 Updates
March 2009 Updates
February 2009 Updates
January 2009 Updates
A Physician's Perspective
ACCP Resources
Help With Players
 

A Physician's Perspective®
An Interactive, Practical Resource From the ACCP


 

Program Overview

  • As chronic obstructive pulmonary disease (COPD) becomes more prevalent and associated mortality rates continue to rise, the need for better treatment options and different delivery systems is high. This podcast will provide the most current information regarding diagnostic tools and treatment opportunities. Presenters will also review advanced studies and ideas for future treatments and other pharmacologic options.

Educational Objectives

  • Evaluate new diagnostic tools and treatment options.
  • Evaluate and discuss future COPD treatment options and studies.
  • Compare and contrast different delivery systems in COPD.

Needs Statement

  • The overall approach to managing stable COPD should be characterized by an increase in treatment, depending on the severity of the disease and the clinical status of the patient. The podcast will provide the most current information regarding diagnostic tools and treatment opportunities.

Video Summary

  • Therapeutic options in pulmonary disease are rapidly evolving with a range of new pharmacologic agents available or under development. Targeting these agents to the lung is accepted as a crucial component of therapy. As such, it is important to appreciate the large number of devices for drug delivery that are currently available. Similarly, the ability to select individual devices based on the age and capability of patient, as well as the cost to third-party payers and the patient, are important. Increasingly, the Food and Drug Administration has become involved in approving specific devices and emphasizing the need to create simplicity and reproducible delivery of a wide range of therapeutic compounds. This presentation will present the current state-of-the-art devices used to deliver medications to the lungs of patients.

Faculty Disclaimer

  • Fernando J. Martinez, MD
    Consultant fee, speaker bureau, advisory committee: ALTANA Pharma, Boehringer Ingelheim, GlaxoSmithKline, Pfizer and sanofi-aventis

Search Archives
Search the ACCP archives for CME and non-CME related material. To see our entire archive put a * in the field below and hit search.

Submit Feedback
The ACCP is interested in your feedback concerning A Physician's Perspective®.

Name:



*Input text from image bellow:





ACCP Opportunities


 

 
A PHYSICIAN'S PERSPECTIVE

   H1N1 (Swine) Flu
   Preparedness

  Guidelines International
  Network Conference 2010

  Learn More
 

      ACCP Products
      and Courses

  November Is COPD
  Awareness Month

  ACCP Tools and Resources
  November Is Lung Cancer
  Awareness Month

  ACCP Tools and Resources